Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

PETMED EXPRESS INC

PETS · Nasdaq · CIK 0001040130 · Healthcare · Pharmaceutical Retailers

INSIDER SIGNAL

36.8 / 100

1 buyers · 1 purchase transaction lines · $43.8K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeLow
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+4.7 / 25
Role+14.0 / 20
Recency+1.1 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Role scores low · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
KRULIK DOUGLASCAO and Interim CFO
○○
MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISESTenPercentOwner
●
Willard Jeffrey AllenCEO and President
○
Elkeles TamarDirector
○
Campbell Leslie C.G.Interim CEO and President
○
LaCamp JamesDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISES · $43.8K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-06-08–2026-06-08

Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

36.8 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 37.0
  2. 37.0
  3. 36.9
  4. 36.9
  5. 36.8

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

1Purchases
0Sales
15Other Form 4 lines
16SEC filings · 365 days
BUYING1 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER8 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-24.1%
3M
-32.5%
6M
-43.9%
12M
-49.8%

Volatility & liquidity

Volatility
84.0%
Beta
—
Avg daily value
USD 142,076

Valuation

Market cap
USD 28.0M
P/E
—

Fundamentals

Profit margin
-32.0%
ROE
-198.0%
Industry
Pharmaceutical Retailers

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2026-03-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-07 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
691,516
Previous report
569,173
Avg daily volume
164,245
Days to cover
4.2

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-08MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISESPurchase (P)Common Stock25,000USD 1.75USD 43,750SEC filing ↗
2025-08-13Silvercape Investments LtdPurchase (P)Common Stock, par value $0.001101,000USD 3.17USD 320,170SEC filing ↗
2025-08-01Silvercape Investments LtdPurchase (P)Common Stock, par value $0.001118,200USD 3.21USD 379,422SEC filing ↗
2025-07-21MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISESPurchase (P)Common Stock25,000USD 3.50USD 87,500SEC filing ↗
2025-07-18Silvercape Investments LtdPurchase (P)Common Stock, par value $0.00117,565USD 3.23USD 56,735SEC filing ↗
2025-07-17Silvercape Investments LtdPurchase (P)Common Stock, par value $0.00131,701USD 3.15USD 99,858SEC filing ↗
2025-07-02Silvercape Investments LtdPurchase (P)Common Stock, par value $0.0012,817USD 3.22USD 9,071SEC filing ↗
2025-07-01Silvercape Investments LtdPurchase (P)Common Stock, par value $0.001694USD 3.21USD 2,228SEC filing ↗
2025-06-03MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISESPurchase (P)Common Stock25,000USD 3.94USD 98,500SEC filing ↗
2025-05-21MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISESPurchase (P)Common Stock25,000USD 3.86USD 96,500SEC filing ↗
2025-05-20Silvercape Investments LtdPurchase (P)Common Stock, par value $0.0017,401USD 3.95USD 29,234SEC filing ↗
2025-03-18MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISESPurchase (P)Common Stock100,000USD 4.09USD 409,000SEC filing ↗
2025-03-10MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISESPurchase (P)Common Stock100,000USD 4.11USD 411,000SEC filing ↗
2025-03-03MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISESPurchase (P)Common Stock50,000USD 4.33USD 216,500SEC filing ↗
2025-02-03MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISESPurchase (P)Common Stock25,000USD 4.82USD 120,500SEC filing ↗

Form 4 evidence

16 transaction lines in the latest 365-day window; 123 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-28Willard Jeffrey AllenAward / grant (A)Common Stock250,000USD 0.00USD 0SEC filing ↗
2026-09-17Elkeles TamarAward / grant (A)Common Stock49,923USD 0.00USD 0SEC filing ↗
2026-08-11Campbell Leslie C.G.Award / grant (A)Common Stock60,000USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (16 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-28Willard Jeffrey AllenAward / grant (A)Common Stock250,000USD 0.00USD 0SEC filing ↗
2026-09-17Elkeles TamarAward / grant (A)Common Stock49,923USD 0.00USD 0SEC filing ↗
2026-08-11Campbell Leslie C.G.Award / grant (A)Common Stock60,000USD 0.00USD 0SEC filing ↗
2026-08-11Mennen Justin L.Award / grant (A)Common Stock55,555USD 0.00USD 0SEC filing ↗
2026-08-11LaCamp JamesAward / grant (A)Common Stock55,555USD 0.00USD 0SEC filing ↗
2026-08-11Batushansky PeterAward / grant (A)Common Stock55,555USD 0.00USD 0SEC filing ↗
2026-06-26KRULIK DOUGLASAward / grant (A)Common Stock32,500USD 0.00USD 0SEC filing ↗
2026-06-26KRULIK DOUGLASAward / grant (A)Common Stock32,500USD 0.00USD 0SEC filing ↗
2026-06-08MATZ ZYMAN STEPHANNIE; NINA CAPITAL HOLDINGS INC.; TACHE GALANTE MOISESPurchase (P)Common Stock25,000USD 1.75USD 43,750SEC filing ↗
2026-01-21FULGONI GIAND (D)Common Stock26,057USD 0.00USD 0SEC filing ↗
2025-10-30FULGONI GIANAward / grant (A)Common Stock33,846USD 0.00USD 0SEC filing ↗
2025-10-30Solivan LeahAward / grant (A)Common Stock33,846USD 0.00USD 0SEC filing ↗
2025-10-30Mennen Justin L.Award / grant (A)Common Stock33,846USD 0.00USD 0SEC filing ↗
2025-10-30LaCamp JamesAward / grant (A)Common Stock34,866USD 0.00USD 0SEC filing ↗
2025-10-30KRULIK DOUGLASAward / grant (A)Common Stock20,000USD 0.00USD 0SEC filing ↗
2025-10-30Batushansky PeterAward / grant (A)Common Stock33,846USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerPETS
CIK0001040130
SectorHealthcare
IndustryPharmaceutical Retailers Yahoo Finance
SEC SIC5912 Retail-Drug Stores and Proprietary Stores
ExchangeNasdaq

Data coverage

Local Form 4 history123 transaction lines from 2020-02-14 to 2026-09-28
34 P purchase lines · 27 S sale lines · 62 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.